Rankings
▼
Calendar
MESO FY 2006 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$3M
100.0% margin
Operating Income
-$6M
-222.7% margin
Net Income
-$8M
-294.1% margin
EPS (Diluted)
$-0.15
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$16M
Total Liabilities
$4M
Stockholders' Equity
$12M
Cash & Equivalents
$8M
← FY 2007
All Quarters